Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma

Research output: Contribution to journalJournal articleResearchpeer-review

  1. PET/DW-MRI for evaluating treatment in chronic hepatitis C patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Repeatability of FDG PET/CT metrics assessed in free breathing and deep inspiration breath hold in lung cancer patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The value of FDG PET/CT for follow-up of patients with melanoma: a retrospective analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Surgical Management, Preoperative Tumor Localization, and Histopathology of 80 Patients Operated on for Insulinoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Stomach interference in 82Rb-PET myocardial perfusion imaging

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 177-Lu-labeled active site inhibited factor VII.

    Research output: PatentResearch

View graph of relations

Positron emission tomography/computed tomography (PET/CT) is an important tool to identify occult melanoma metastasis. To date, it is controversial which patients with primary cutaneous melanoma should have staging PET/CT. In this retrospective analysis of more than 800 consecutive patients with cutaneous melanoma, we sought to identify factors predictive of PET/CT positivity in the setting of newly-diagnosed high-risk primary melanoma to determine those patients most appropriate to undergo a PET/CT scan as part of their diagnostic work up. 167 patients with newly-diagnosed high-risk primary cutaneous melanoma underwent a PET/CT scan performed as part of their initial staging. Clinical and histologic factors were evaluated as possible predictors of melanoma metastasis identified on PET/CT scanning using both univariate and multivariate logistic regression. In all, 32 patients (19.2%) had a positive PET/CT finding of metastatic melanoma. In more than half of these patients (56.3%), PET/CT scanning identified disease that was not detectable on clinical examination. Mitotic rate, tumor thickness, lymphadenopathy, and bleeding were significantly predictive of PET/CT positivity. A combinatorial index constructed from these factors revealed a significant association between number of high-risk factors observed and prevalence of PET/CT positivity, which increased from 5.8% (with the presence of 0-2 factors) to 100.0%, when all four factors were present. These results indicate that combining clinical and histologic prognostic factors enables the identification of patients with a higher likelihood of a positive PET/CT scan.

Original languageEnglish
JournalAmerican Journal of Nuclear Medicine and Molecular Imaging
Volume6
Issue number5
Pages (from-to)277-285
Number of pages9
ISSN2160-8407
Publication statusPublished - 2016

ID: 55064618